サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1531866

弱視の世界市場レポート 2024年

Amblyopia Global Market Report 2024

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
弱視の世界市場レポート 2024年
出版日: 2024年08月12日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

弱視の市場規模は、今後数年間で安定した成長が見込まれます。2028年にはCAGR4.7％で55億9,000万米ドルに成長します。予測期間の成長は、デジタルヘルスプラットフォームの拡大、リソースや保護者のサポートの利用可能性の増加、子どもの予防ヘルスケアへの注目の高まり、弱視に対する意識の高まり、眼科専門センターやクリニックの急増などに起因すると考えられます。この期間に予想される主な動向には、診断技術の進歩、新規治療アプローチの開発、視覚発達と神経可塑性の理解の進展、新薬の登場と承認などがあります。

眼科疾患の罹患率の増加は、今後の弱視市場の成長を牽引すると予想されます。眼科疾患には、白内障や緑内障のような一般的な疾患から網膜色素変性症や眼腫瘍のようなまれな疾患まで、眼に影響を及ぼすさまざまな疾患が含まれます。これらの疾患の増加要因としては、スクリーン使用時間の増加、人口の高齢化、汚染などの環境要因が挙げられます。特に弱視は、脳が弱い方の目からの入力を無視するようになるため、眼科疾患を悪化させる可能性があり、放置すると永久的な視力障害や奥行き知覚の問題につながる可能性があります。米国疾病予防管理センター（CDC）によると、2024年1月時点で40歳以上のアメリカ人のうち340万人以上が失明または視覚障害を患っており、この数は2030年までに倍増すると予想されています。したがって、眼科疾患の有病率の上昇は、弱視市場の成長を促す要因となっています。

弱視市場の主要企業は、患者により良い治療を提供するために、デジタル治療薬などの治療技術の進歩を優先しています。デジタル・セラピューティクスは、医学的疾患や疾病の予防、管理、治療を目的とした高度なソフトウェア・プログラムによるエビデンスに基づく介入です。デジタル・セラピューティクスは、多くの場合デジタル・プラットフォームによって促進される行動やライフスタイルの変化を活用して、健康上の成果を向上させるもので、従来の治療法とは独立して、あるいは並行して使用することができます。例えば、米国のバイオテクノロジー企業であるルミノピア社は、2021年9月にデジタル治療薬「ルミノピアOne」のFDA承認を取得しました。この革新的な治療法は、弱視と診断された小児の視力を強化するためにテレビ番組を利用するもので、小児の神経視覚障害に対するデジタル治療法として初めてFDAに承認され、弱視の治療法として初めてテレビ番組を採用しました。105人の小児を対象とした第3相臨床試験の結果、治療を受けた小児の視力は対照群と比較して統計的に有意に改善し、平均視力はそれぞれ1.8線対0.8線でした。さらに、治療を受けた患者の62％が2線以上の改善と定義される強固な反応を示したのに対し、対照群では33％でした。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の弱視市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の弱視市場の実績：規模と成長, 2018-2023
  • 世界の弱視市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界の弱視市場：疾患タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 斜視弱視
  • 屈折弱視
  • 剥奪弱視
  • 逆弱視
  • 世界の弱視市場：診断別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 視力検査
  • フォトスクリーナー
  • ブルックナーテスト
  • その他の診断
  • 世界の弱視市場：治療別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • アイパッチ
  • アトロピン点眼薬
  • 眼鏡
  • ビデオゲーム
  • その他の治療法
  • 世界の弱視市場：エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 地域別・国別分析

  • 世界の弱視市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界の弱視市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 弱視市場：競合情勢
  • 弱視市場：企業プロファイル
    • Novartis AG
    • Takeda Pharmaceutical Company Limited
    • Biocon Limited
    • Astellas Pharma Inc.
    • Alcon Vision LLC

第31章 その他の大手企業と革新的企業

  • Bausch Health Companies Inc.
  • HOYA Corp.
  • UnityPoint Health
  • Integra LifeSciences
  • Wockhardt Ltd.
  • Welch Allyn
  • Heidelberg Engineering Inc.
  • Orbis International
  • Oculus Optikgerate GmbH
  • Ocutrx Vision Technologies LLC
  • AccuVision
  • Vivid Vision Inc.
  • Fresnel Prism and Lens Co.
  • RevitalVision
  • WOW Vision Therapy

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r18777

Amblyopia, commonly referred to as lazy eye, is a condition affecting the development of vision where one eye does not achieve normal visual acuity, even with corrective eyewear such as glasses or contact lenses. Typically beginning in infancy or early childhood, amblyopia occurs due to a lack of proper coordination between the eye and the brain. As time progresses, the brain starts to favor the eye with better vision, leading to further deterioration of the weaker eye.

There are several types of amblyopia strabismus amblyopia, refractive amblyopia, deprivation amblyopia, and reverse amblyopia. Strabismus amblyopia results from misalignment of the eyes, causing a discrepancy in visual acuity between them. Diagnosis involves visual acuity tests, photo screening, Bruckner tests, and others. Treatment options include the use of eye patches, atropine drops, corrective glasses, and sometimes even therapeutic video games. Amblyopia affects diverse sectors including hospital pharmacies, retail pharmacies, and online pharmacies.

The amblyopia market research report is one of a series of new reports from The Business Research Company that provides amblyopia market statistics, including amblyopia industry global market size, regional shares, competitors with a amblyopia market share, detailed amblyopia market segments, market trends and opportunities, and any further data you may need to thrive in the amblyopia industry. This amblyopia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The amblyopia market size has grown steadily in recent years. It will grow from $4.45 billion in 2023 to $4.65 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The increase during the historical period can be credited to a rise in ophthalmic disorders, growing consumer demand for affordable eyewear, the prevalence of hyperopia and myopia, a larger elderly population, and increased adoption of telemedicine.

The amblyopia market size is expected to see steady growth in the next few years. It will grow to $5.59 billion in 2028 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to the expansion of digital health platforms, increased availability of resources and parental support, greater focus on preventive healthcare for children, rising awareness about amblyopia, and the proliferation of specialized eye care centers and clinics. Key trends anticipated in this period include advancements in diagnostic technologies, development of novel treatment approaches, progress in understanding visual development and neuroplasticity, as well as the introduction and approval of new pharmaceuticals.

The increasing incidence of ophthalmological diseases is expected to drive growth in the amblyopia market moving forward. Ophthalmological diseases encompass a spectrum of disorders affecting the eyes, ranging from common ailments such as cataracts and glaucoma to rarer conditions such as retinitis pigmentosa and ocular tumors. Factors contributing to the rise in these diseases include increased screen time, aging populations, and environmental factors such as pollution. Amblyopia, in particular, can exacerbate ophthalmological conditions by causing the brain to disregard input from the weaker eye, potentially leading to permanent vision impairment and issues with depth perception if left untreated. According to the Centers for Disease Control and Prevention (CDC), over 3.4 million Americans aged 40 years and older were blind or visually impaired in January 2024, a number expected to double by 2030. Therefore, the escalating prevalence of ophthalmological diseases is a key driver behind the growth of the amblyopia market.

Major companies in the amblyopia market are prioritizing advancements in treatment technologies, such as digital therapeutics, to better cater to patients. Digital therapeutics are evidence-based interventions driven by sophisticated software programs aimed at preventing, managing, or treating medical disorders or diseases. They leverage behavioral and lifestyle changes, often facilitated by digital platforms, to enhance health outcomes and can be used independently or alongside traditional therapies. For instance, Luminopia Inc., a US-based biotechnology company, achieved FDA approval in September 2021 for its digital therapeutic, Luminopia One. This innovative treatment utilizes television shows to enhance vision in children diagnosed with amblyopia, marking the first FDA-approved digital therapeutic for a neuro-visual disorder in children and the first to employ TV shows as a treatment for amblyopia. Results from a phase 3 pivotal trial involving 105 children demonstrated a statistically significant improvement in visual acuity among those receiving treatment compared to controls, with an average improvement of 1.8 lines versus 0.8 lines, respectively. Furthermore, 62% of treated patients exhibited a robust response, defined as a 2-line or greater improvement, compared to 33% in the control group.

In October 2022, Sumitomo Corporation, a Japan-based electrical services company, partnered with Juntendo University to develop a virtual reality (VR) app for amblyopia treatment. This app aims to enhance treatment engagement and efficacy by making therapy more interactive and enjoyable for children. Juntendo University, a prominent private university in Japan, is collaborating to leverage VR technology in optimizing amblyopia treatment protocols.

Major companies operating in the amblyopia market are Novartis AG, Takeda Pharmaceutical Company Limited, Biocon Limited, Astellas Pharma Inc., Alcon Vision LLC, Bausch Health Companies Inc., HOYA Corp., UnityPoint Health, Integra LifeSciences, Wockhardt Ltd., Welch Allyn, Heidelberg Engineering Inc., Orbis International, Oculus Optikgerate GmbH, Ocutrx Vision Technologies LLC, AccuVision, Vivid Vision Inc., Fresnel Prism and Lens Co., RevitalVision, WOW Vision Therapy, Lancastle International Ltd., Novasight, Eyenovia Inc., Adaptica Srl, AmblyoPlay

North America was the largest region in the amblyopia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amblyopia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the amblyopia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The amblyopia market consists of revenues earned by entities by providing services such as screening and diagnosis, vision therapy, patching therapy, and orthoptic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The amblyopia market also includes sales of contact lenses, vision therapy software, lighting products, bangerter filters, and spectacle lenses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Amblyopia Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on amblyopia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for amblyopia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The amblyopia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease Type: Strabismus Amblyopia; Refractive Amblyopia; Deprivation Amblyopia; Reverse Amblyopia
  • 2) By Diagnosis: Visual Acuity Tests; Photo Screening; Bruckner Test; Other Diagnosis
  • 3) By Treatment: Eye Patches; Atropine Drops; Glasses; Video Games; Other Treatments
  • 4) By End User: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
  • Companies Mentioned: Novartis AG; Takeda Pharmaceutical Company Limited; Biocon Limited; Astellas Pharma Inc.; Alcon Vision LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Amblyopia Market Characteristics

3. Amblyopia Market Trends And Strategies

4. Amblyopia Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Amblyopia Market Size and Growth

  • 5.1. Global Amblyopia Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Amblyopia Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Amblyopia Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Amblyopia Market Segmentation

  • 6.1. Global Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Strabismus Amblyopia
  • Refractive Amblyopia
  • Deprivation Amblyopia
  • Reverse Amblyopia
  • 6.2. Global Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Visual Acuity Tests
  • Photo Screening
  • Bruckner Test
  • Other Diagnosis
  • 6.3. Global Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Eye Patches
  • Atropine Drops
  • Glasses
  • Video Games
  • Other Treatments
  • 6.4. Global Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

7. Amblyopia Market Regional And Country Analysis

  • 7.1. Global Amblyopia Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Amblyopia Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Amblyopia Market

  • 8.1. Asia-Pacific Amblyopia Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Amblyopia Market

  • 9.1. China Amblyopia Market Overview
  • 9.2. China Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Amblyopia Market

  • 10.1. India Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Amblyopia Market

  • 11.1. Japan Amblyopia Market Overview
  • 11.2. Japan Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Amblyopia Market

  • 12.1. Australia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Amblyopia Market

  • 13.1. Indonesia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Amblyopia Market

  • 14.1. South Korea Amblyopia Market Overview
  • 14.2. South Korea Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Amblyopia Market

  • 15.1. Western Europe Amblyopia Market Overview
  • 15.2. Western Europe Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Amblyopia Market

  • 16.1. UK Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Amblyopia Market

  • 17.1. Germany Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Amblyopia Market

  • 18.1. France Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Amblyopia Market

  • 19.1. Italy Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Amblyopia Market

  • 20.1. Spain Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Amblyopia Market

  • 21.1. Eastern Europe Amblyopia Market Overview
  • 21.2. Eastern Europe Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Amblyopia Market

  • 22.1. Russia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Amblyopia Market

  • 23.1. North America Amblyopia Market Overview
  • 23.2. North America Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Amblyopia Market

  • 24.1. USA Amblyopia Market Overview
  • 24.2. USA Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Amblyopia Market

  • 25.1. Canada Amblyopia Market Overview
  • 25.2. Canada Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Amblyopia Market

  • 26.1. South America Amblyopia Market Overview
  • 26.2. South America Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Amblyopia Market

  • 27.1. Brazil Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Amblyopia Market

  • 28.1. Middle East Amblyopia Market Overview
  • 28.2. Middle East Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Amblyopia Market

  • 29.1. Africa Amblyopia Market Overview
  • 29.2. Africa Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Amblyopia Market Competitive Landscape And Company Profiles

  • 30.1. Amblyopia Market Competitive Landscape
  • 30.2. Amblyopia Market Company Profiles
    • 30.2.1. Novartis AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Takeda Pharmaceutical Company Limited
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Biocon Limited
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Astellas Pharma Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Alcon Vision LLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Amblyopia Market Other Major And Innovative Companies

  • 31.1. Bausch Health Companies Inc.
  • 31.2. HOYA Corp.
  • 31.3. UnityPoint Health
  • 31.4. Integra LifeSciences
  • 31.5. Wockhardt Ltd.
  • 31.6. Welch Allyn
  • 31.7. Heidelberg Engineering Inc.
  • 31.8. Orbis International
  • 31.9. Oculus Optikgerate GmbH
  • 31.10. Ocutrx Vision Technologies LLC
  • 31.11. AccuVision
  • 31.12. Vivid Vision Inc.
  • 31.13. Fresnel Prism and Lens Co.
  • 31.14. RevitalVision
  • 31.15. WOW Vision Therapy

32. Global Amblyopia Market Competitive Benchmarking

33. Global Amblyopia Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Amblyopia Market

35. Amblyopia Market Future Outlook and Potential Analysis

  • 35.1 Amblyopia Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Amblyopia Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Amblyopia Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer